FOX BIZ NEWS: 23andMe, GlaxoSmithKline deal raising concerns over privacy

23andMe, GlaxoSmithKline deal raising concerns over privacy



Fox News medical correspondent Dr. Marc Siegel on the promising signs in Biogen's Alzheimer's new treatment, GlaxoSmithKline buying a stake in 23andMe and the potential privacy concerns over the genetic service.

via FOX BUSINESS NEWS https://ift.tt/2JXdwPL